About Systagenix
Systagenix is a company based in Horley (United Kingdom) founded in 2008 was acquired by Scapa Group in September 2018. Systagenix operates in a competitive market with competitors including Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
- Headquarter Horley, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Systagenix Wound Management, Limited
- Date of Incorporation 27 Aug, 2008
- Jurisdiction BRACKNELL, BERKSHIRE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
-$852.81 (USD)13as on Dec 31, 2015
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Acelity
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Systagenix
Detailed funding history for Systagenix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Systagenix
Systagenix has secured backing from 2 investors. Prominent investors backing the company include Acelity and Scapa Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wound therapeutics and regenerative medicine products are developed globally.
|
Locked | Locked | Locked | |
|
Adhesive-based products for healthcare and industrial sectors are manufactured.
|
Locked | Locked | Locked |
Investor details for Systagenix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Systagenix
Investment portfolio details for Systagenix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Systagenix
Detailed financials for Systagenix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Systagenix Comparisons
Peer comparison for Systagenix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Systagenix
Systagenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| Locked | Locked | Locked |
Biomaterials and devices for internal wound healing are developed.
|
|
| Locked | Locked | Locked |
Dressing materials and medical devices
|
|
| Locked | Locked | Locked |
Wound-healing therapies for oral surgery and chronic wounds are developed.
|
Detailed competitors of Systagenix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Systagenix
Complete news archive for Systagenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Systagenix
Systagenix was founded in 2008.
Systagenix is headquartered in Horley, United Kingdom. It is registered at Horley, Surrey, United Kingdom.
Systagenix was established in 2008 through the acquisition of Johnson Johnsons wound-care business by One Equity Partners, a JPMorgan Chase affiliate. Products are focused on advanced wound therapeutics and regenerative medicine, encompassing antimicrobial solutions, odor management, hydration, granulation promotion, adherence minimization, exudate control, and compression. The company operates from Horley, United Kingdom, and was acquired by Kinetic Concepts for 485 million in 2013.
Systagenix's top competitors include Imbed Biosciences, Cresilon and Kane Biotech.
Systagenix has 2 investors. Key investors include Acelity, and Scapa Group.